Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Gains from Investment Securities (2020 - 2025)

Treace Medical Concepts' Gains from Investment Securities history spans 6 years, with the latest figure at $599000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 267.32% year-over-year to $599000.0; the TTM value through Dec 2025 reached -$15.1 million, up 3.81%, while the annual FY2025 figure was $7.2 million, 7.62% down from the prior year.
  • Gains from Investment Securities reached $599000.0 in Q4 2025 per TMCI's latest filing, down from $852220.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.8 million in Q3 2021 to a low of -$15.2 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is -$21203.3, with a median of $771785.0 recorded in 2023.
  • Peak YoY movement for Gains from Investment Securities: surged 7758.91% in 2021, then crashed 74.63% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $1.8 million in 2021, then tumbled by 947.65% to -$15.2 million in 2022, then skyrocketed by 98.65% to -$205000.0 in 2023, then plummeted by 74.63% to -$358000.0 in 2024, then surged by 267.32% to $599000.0 in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Gains from Investment Securities are $599000.0 (Q4 2025), $852220.0 (Q3 2025), and $852220.0 (Q2 2025).